Manufacturer record

Mayoford Pharma: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Mayoford Pharma (Himachal Pradesh) were declared Not of Standard Quality between December 2023 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

5 records linked to Mayoford Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2023 to Mar 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2023
4
Products affected
Assay
Most common failure
Mar 2026
Latest alert

Flagged batches per year

2023 · 12025 · 12026 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefixime, Ofloxacin & (Lactic Acid Bacillus) Tablets MBT-24239Mfg 2024-12 · Exp 2026-11 Test for Uniformity of WeightUniformity of weight/content DTL, Bengaluru, KarnatakaState lab Mar 2026
Methylcobalamin, Alpha Lipoic Acid, Inositol Folic Acid, Chromium Picolinate, Selenium Dioxide & Benfotiamine Capsules MMC-2902Mfg 2025-06 · Exp 2026-11 Assay for Benfortiamine and Alpha Lipoic AcidAssay DTL, Bengaluru, KarnatakaState lab Feb 2026
Cefixime & Ofloxacin Tablets MBT-24775Mfg 2025-09 · Exp 2027-08 The sample does not conform to the claim with respect to Assay of Anhydrous Cefixime.Assay DTL JaipurState lab Jan 2026
Pregabalin & Methlcobalamin Capsules IP (Neujan Capsules) MMC-1957Mfg 2024-01 · Exp 2025-12 Test for Uniformity of WeightUniformity of weight/content DTL, Bengaluru, KarnatakaState lab Oct 2025
Pregabalin Capsules IP (Pragavir Capsules) MMC-1476Mfg 2023-06 · Exp 2025-05 Assay of PregabalinAssay RDTL ChandigarhState lab Dec 2023

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.